{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:24:47Z","timestamp":1754162687701,"version":"3.41.2"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Ischemic heart disease (IHD) in pregnancy presents significant risks to both mother and fetus, especially as cardiovascular risk factors become more prevalent in women of reproductive age. This literature review examines the epidemiology, pathophysiology, clinical impact, and multidisciplinary management of IHD during pregnancy. Maternal complications include acute coronary syndrome, heart failure, and arrhythmias, with fetal risks such as preterm birth, intrauterine growth restriction, and neonatal death. Physiological and hematologic adaptations of pregnancy exacerbate ischemic risk, particularly in women with underlying atherosclerosis. Evidence-based pharmacologic and interventional strategies are discussed, alongside delivery planning and postpartum care. A coordinated, multidisciplinary approach remains essential to improving outcomes in this high-risk population.<\/jats:p>","DOI":"10.1097\/crd.0000000000001013","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:00:53Z","timestamp":1753880453000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy and Ischemic Heart Disease: A Review of Risks and Therapeutic Approaches"],"prefix":"10.1097","author":[{"given":"Ellen N.","family":"Huhulea","sequence":"first","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esewi","family":"Aifuwa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Departments of Cardiology and Medicine, Westchester Medicine and New York Medical College, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1741826711432117","article-title":"Myocardial infarction in pregnancy and postpartum in the UK.","volume":"20","author":"Bush","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association.","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.amjcard.2019.01.030","article-title":"Trends in incidence and outcomes of pregnancy-related acute myocardial infarction (from a nationwide inpatient sample database).","volume":"123","author":"Tripathi","year":"2019","journal-title":"Am J Cardiol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.mayocp.2018.04.019","article-title":"Acute myocardial infarction during pregnancy and the puerperium in the United States.","volume":"93","author":"Smilowitz","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11883-021-00944-1","article-title":"Management of ischemic heart disease in pregnancy.","volume":"23","author":"Chavez","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.105.576751","article-title":"Acute myocardial infarction in pregnancy: a United States population-based study.","volume":"113","author":"James","year":"2006","journal-title":"Circulation"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines.","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehs270","article-title":"Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology.","volume":"34","author":"Roos-Hesselink","year":"2013","journal-title":"Eur Heart J"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2008.03.049","article-title":"Acute myocardial infarction associated with pregnancy.","volume":"52","author":"Roth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/heartjnl-2014-306676","article-title":"Pregnancy risks in women with pre-existing coronary artery disease, or following acute coronary syndrome.","volume":"101","author":"Burchill","year":"2015","journal-title":"Heart"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"e015490","DOI":"10.1161\/JAHA.119.015490","article-title":"Acute coronary syndrome and ischemic heart disease in pregnancy: data from the EURObservational Research Programme-European Society of Cardiology Registry of Pregnancy and Cardiac Disease.","volume":"9","author":"Baris","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1139\/cjpp-2024-0010","article-title":"Cardiac physiology and pathophysiology in pregnancy.","volume":"102","author":"Rizi","year":"2024","journal-title":"Can J Physiol Pharmacol"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIR.0000000000000300","article-title":"Cardiac arrest in pregnancy: a scientific statement from the American Heart Association.","volume":"132","author":"Jeejeebhoy","year":"2015","journal-title":"Circulation"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/heartjnl-2018-314364","article-title":"Pregnancy in women with pre-existent ischaemic heart disease: a systematic review with individualised patient data.","volume":"105","author":"Lameijer","year":"2019","journal-title":"Heart"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1080\/14767058.2021.1941851","article-title":"Cardiovascular complications following cesarean section and vaginal delivery: a national population-based study.","volume":"35","author":"Larsson","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.chest.2016.05.021","article-title":"Risks of venous thromboembolism after cesarean sections: a meta-analysis.","volume":"150","author":"Blondon","year":"2016","journal-title":"Chest"},{"issue":"5 Pt 1","key":"R17-20250730","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.AOG.0000124568.71597.ce","article-title":"Maternal morbidity associated with vaginal versus cesarean delivery.","volume":"103","author":"Burrows","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/aogs.14408","article-title":"Planned cesarean section vs planned vaginal delivery among women without formal medical indication for planned cesarean section: a retrospective cohort study of maternal short-term complications.","volume":"101","author":"Dahlquist","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"18 Suppl 3","key":"R19-20250730","first-page":"S829","article-title":"Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.","volume":"122","author":"Vanden Hoek","year":"2010","journal-title":"Circulation"},{"key":"R20-20250730","first-page":"2026","article-title":"Coronary events in the pregnant patient: who is at risk and how best to manage?","volume":"37","author":"Samuel","year":"2021","journal-title":"Can J Cardiol"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bpobgyn.2014.03.011","article-title":"Heart disease in pregnancy: ischaemic heart disease.","volume":"28","author":"Fryearson","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1093\/eurheartj\/ehab546","article-title":"Management of acute cardiovascular complications in pregnancy.","volume":"42","author":"Egidy Assenza","year":"2021","journal-title":"Eur Heart J"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"101295","DOI":"10.1016\/j.ajogmf.2024.101295","article-title":"Ischemic heart disease in pregnancy: a practical approach to management.","volume":"6","author":"Nguyen","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R24-20250730","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2018.02.076","article-title":"Pregnancy outcomes in women with heart disease: the CARPREG II study.","volume":"71","author":"Silversides","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R26-20250730","first-page":"1011","article-title":"Assessing cardiac risk in pregnant women with heart disease: how risk scores are created and their role in clinical practice.","volume":"36","author":"D\u2019Souza","year":"2020","journal-title":"Can J Cardiol"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.semperi.2014.04.020","article-title":"Ischemic heart disease in pregnancy.","volume":"38","author":"Turitz","year":"2014","journal-title":"Semin Perinatol"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jacc.2021.01.057","article-title":"Management of women with acquired cardiovascular disease from pre-conception through pregnancy and postpartum.","volume":"77","author":"Park","year":"2021","journal-title":"JACC"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1471-0528.12522","article-title":"Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.","volume":"121","author":"Ersboll","year":"2014","journal-title":"BJOG"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.str.0000442009.06663.48","article-title":"Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"45","author":"Bushnell","year":"2014","journal-title":"Stroke"},{"key":"R31-20250730","first-page":"185","article-title":"Coronary artery disease and myocardial infarction in pregnancy: a review of epidemiology, diagnosis, and medical and surgical management.","volume":"26","author":"Kealey","year":"2010","journal-title":"Can J Cardiol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/HCO.0000000000001039","article-title":"Cardiac medications in obstetric patients.","volume":"38","author":"Spehar","year":"2023","journal-title":"Curr Opin Cardiol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review.","volume":"73","author":"Halpern","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.","volume":"126","author":"Lefkou","year":"2016","journal-title":"J Clin Invest"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"1003060","DOI":"10.3389\/fphar.2022.1003060","article-title":"The effect of statins exposure during pregnancy on congenital anomalies and spontaneous abortions: a systematic review and meta-analysis.","volume":"13","author":"Hirsch","year":"2022","journal-title":"Front Pharmacol"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC).","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/WHE.13.70","article-title":"Treating cardiac disease in pregnancy.","volume":"10","author":"Alonso-Gonzalez","year":"2014","journal-title":"Womens Health (Lond)"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"77.e1","DOI":"10.1016\/j.ajog.2019.07.019","article-title":"Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease.","volume":"222","author":"Easter","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1161\/CIR.0000000000001121","article-title":"Anesthetic care of the pregnant patient with cardiovascular disease: a scientific statement from the American Heart Association.","volume":"147","author":"Meng","year":"2023","journal-title":"Circulation"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41372-023-01625-4","article-title":"Mode of delivery among women with maternal cardiac disease.","volume":"43","author":"Gavin","year":"2023","journal-title":"J Perinatol"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee.","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/AOG.0000000000005151","article-title":"Association of neighborhood socioeconomic disadvantage and postpartum readmission.","volume":"141","author":"Meiman","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2023.01.042","article-title":"Assessing and addressing social determinants of cardiovascular health: JACC state-of-the-art review.","volume":"81","author":"Brandt","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"e084212","DOI":"10.1136\/bmjopen-2024-084212","article-title":"Barriers and facilitators of cardiovascular disease prevention services for women with prior gestational diabetes or hypertensive disorders of pregnancy in low-income, middle-income and high-income settings: a scoping review protocol.","volume":"14","author":"Quansah","year":"2024","journal-title":"BMJ Open"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"i2793","DOI":"10.1136\/bmj.i2793","article-title":"Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.","volume":"353","author":"Kypridemos","year":"2016","journal-title":"BMJ"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:00:59Z","timestamp":1753880459000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001013","relation":{},"ISSN":["1538-4683"],"issn-type":[{"type":"electronic","value":"1538-4683"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}